No abstract available
MeSH terms
-
Arterial Occlusive Diseases / therapy*
-
Basilar Artery / pathology*
-
Cohort Studies
-
Fibrinolytic Agents / administration & dosage
-
Humans
-
Prognosis
-
Risk
-
Thrombolytic Therapy / methods*
-
Tissue Plasminogen Activator / therapeutic use
-
Treatment Outcome
-
Urokinase-Type Plasminogen Activator / therapeutic use
Substances
-
Fibrinolytic Agents
-
Tissue Plasminogen Activator
-
Urokinase-Type Plasminogen Activator